Healthcare provider profile · identity verified

Loren C Fuglestad, MD

Family Practice · GREEN BAY, WI · NPI 1669456463

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	643	169
Amlodipine Besylate	Amlodipine Besylate	277	77
Losartan Potassium	Losartan Potassium	265	72
Omeprazole	Omeprazole	247	74
Lisinopril	Lisinopril	246	68
Rosuvastatin Calcium	Rosuvastatin Calcium	243	67
Metoprolol Succinate	Metoprolol Succinate	239	67
Levothyroxine Sodium	Levothyroxine Sodium	213	48
Tamsulosin Hcl	Tamsulosin Hcl	176	48
Furosemide	Furosemide	150	40
Metformin Hcl Er	Metformin Hcl	146	45
Allopurinol	Allopurinol	137	36
Simvastatin	Simvastatin	123	33
Pantoprazole Sodium	Pantoprazole Sodium	122	29
Sertraline Hcl	Sertraline Hcl	115	30
Hydrochlorothiazide	Hydrochlorothiazide	104	31
Gabapentin	Gabapentin	102	28
Metformin Hcl	Metformin Hcl	100	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	88	27
Eliquis	Apixaban	76	18
Metoprolol Tartrate	Metoprolol Tartrate	76	21
Lorazepam	Lorazepam	73	13
Tramadol Hcl	Tramadol Hcl	70	15
Donepezil Hcl	Donepezil Hcl	68	11
Potassium Chloride	Potassium Chloride	64	18
Carvedilol	Carvedilol	63	19
Memantine Hcl	Memantine Hcl	62	suppressed
Meloxicam	Meloxicam	60	21
Glimepiride	Glimepiride	56	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	56	17
Pioglitazone Hcl	Pioglitazone Hcl	55	16
Fluoxetine Hcl	Fluoxetine Hcl	52	15
Albuterol Sulfate Hfa	Albuterol Sulfate	49	27
Prednisone	Prednisone	48	27
Citalopram Hbr	Citalopram Hydrobromide	47	suppressed
Finasteride	Finasteride	46	14
Xarelto	Rivaroxaban	45	suppressed
Trazodone Hcl	Trazodone Hcl	43	suppressed
Diclofenac Sodium	Diclofenac Sodium	41	23
Ezetimibe	Ezetimibe	40	13
Trulicity	Dulaglutide	39	suppressed
Duloxetine Hcl	Duloxetine Hcl	38	11
Warfarin Sodium	Warfarin Sodium	37	14
Atenolol	Atenolol	36	suppressed
Bupropion Xl	Bupropion Hcl	36	suppressed
Clonazepam	Clonazepam	36	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	36	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Fluticasone Propionate	Fluticasone Propionate	33	15
Lovastatin	Lovastatin	33	suppressed
Pravastatin Sodium	Pravastatin Sodium	32	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Tizanidine Hcl	Tizanidine Hcl	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Alendronate Sodium	Alendronate Sodium	27	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	11
Lamotrigine	Lamotrigine	27	suppressed
Myrbetriq	Mirabegron	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Jardiance	Empagliflozin	26	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Baclofen	Baclofen	24	suppressed
Famotidine	Famotidine	24	suppressed
Glipizide	Glipizide	24	suppressed
Clopidogrel	Clopidogrel Bisulfate	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Glipizide Er	Glipizide	22	suppressed
Topiramate	Topiramate	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Oxycodone Hcl	Oxycodone Hcl	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Sildenafil Citrate	Sildenafil Citrate	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Montelukast Sodium	Montelukast Sodium	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Dutasteride	Dutasteride	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Valsartan	Valsartan	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Oxycontin	Oxycodone Hcl	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Celecoxib	Celecoxib	14	suppressed
Elmiron	Pentosan Polysulfate Sodium	14	suppressed
Naproxen	Naproxen	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Diazepam	Diazepam	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	11
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	11
Tradjenta	Linagliptin	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error